SECREFLO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Secreflo, and when can generic versions of Secreflo launch?
Secreflo is a drug marketed by Chirhoclin and is included in one NDA.
The generic ingredient in SECREFLO is secretin synthetic porcine. There is one drug master file entry for this compound. Additional details are available on the secretin synthetic porcine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SECREFLO?
- What are the global sales for SECREFLO?
- What is Average Wholesale Price for SECREFLO?
Summary for SECREFLO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 17 |
| Patent Applications: | 198 |
| DailyMed Link: | SECREFLO at DailyMed |
US Patents and Regulatory Information for SECREFLO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chirhoclin | SECREFLO | secretin synthetic porcine | FOR SOLUTION;INTRAVENOUS | 021136-001 | Apr 4, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
